Literature DB >> 11443765

Epidemiology of cardiovascular risk factors in chronic renal disease.

J Coresh1, J C Longenecker, E R Miller, H J Young, M J Klag.   

Abstract

Treatment and prevention of cardiovascular disease in the general population has benefited greatly from the identification of cardiovascular disease risk factors. Given the particularly high risk of cardiovascular disease and total mortality among patients with chronic renal insufficiency (CRI) and end-stage renal disease (ESRD), it is important to assess the role of traditional and nontraditional risk factors for cardiovascular disease. This review discusses the foundations of risk factor epidemiology and briefly summarizes the evidence regarding cardiovascular risk factors in renal disease. Diabetes and hypertension have a very high prevalence in patients with CRI. Patients with CRI and ESRD also have a higher frequency of cardiac dysfunction and left ventricular hypertrophy, which further increase the risk of cardiovascular disease. Finally, patients with renal disease have a higher prevalence of less established risk factors, including low HDL, and high triglycerides, lipoprotein(a), and homocysteine, where prospective studies and clinical trials are needed to provide a scientific basis for reduction of cardiovascular risk among patients with renal disease.

Entities:  

Mesh:

Year:  1998        PMID: 11443765

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  30 in total

Review 1.  Epidemiology, diagnosis, and management of cardiac disease in chronic renal disease.

Authors:  M J Sarnak; A S Levey
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

2.  Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis.

Authors:  Winfried März; Bernd Genser; Christiane Drechsler; Vera Krane; Tanja B Grammer; Eberhard Ritz; Tatjana Stojakovic; Hubert Scharnagl; Karl Winkler; Ingar Holme; Hallvard Holdaas; Christoph Wanner
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 8.237

3.  Change in cardiovascular risk factors with progression of kidney disease.

Authors:  Linda F Fried; Ronit Katz; Mary Cushman; Mark Sarnak; Michael G Shlipak; Lewis Kuller; Anne B Newman
Journal:  Am J Nephrol       Date:  2008-10-24       Impact factor: 3.754

Review 4.  Accuracy and limitations of the diagnosis of malnutrition in dialysis patients.

Authors:  Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2012-06-26       Impact factor: 3.455

5.  Serum apolipoprotein B is inversely associated with eccentric left ventricular hypertrophy in peritoneal dialysis patients.

Authors:  Min Ye; Yanqiu Liu; Haoyu Wang; Na Tian; Wei Li; Wei He; Hong Lin; Rui Fan; Cuiling Li; Donghong Liu; Fengjuan Yao
Journal:  Int Urol Nephrol       Date:  2017-11-10       Impact factor: 2.370

6.  Intensive blood-pressure control in hypertensive chronic kidney disease.

Authors:  Lawrence J Appel; Jackson T Wright; Tom Greene; Lawrence Y Agodoa; Brad C Astor; George L Bakris; William H Cleveland; Jeanne Charleston; Gabriel Contreras; Marquetta L Faulkner; Francis B Gabbai; Jennifer J Gassman; Lee A Hebert; Kenneth A Jamerson; Joel D Kopple; John W Kusek; James P Lash; Janice P Lea; Julia B Lewis; Michael S Lipkowitz; Shaul G Massry; Edgar R Miller; Keith Norris; Robert A Phillips; Velvie A Pogue; Otelio S Randall; Stephen G Rostand; Miroslaw J Smogorzewski; Robert D Toto; Xuelei Wang
Journal:  N Engl J Med       Date:  2010-09-02       Impact factor: 91.245

7.  Antihypertensive medication use and change in kidney function in elderly adults: a marginal structural model analysis.

Authors:  Michelle C Odden; Ira B Tager; Mark J van der Laan; Joseph A C Delaney; Carmen A Peralta; Ronit Katz; Mark J Sarnak; Bruce M Psaty; Michael G Shlipak
Journal:  Int J Biostat       Date:  2011-09-08       Impact factor: 0.968

8.  Kidney disease and the cumulative burden of life course socioeconomic conditions: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  David A Shoham; Suma Vupputuri; Jay S Kaufman; Abhijit V Kshirsagar; Ana V Diez Roux; Josef Coresh; Gerardo Heiss
Journal:  Soc Sci Med       Date:  2008-07-28       Impact factor: 4.634

9.  Associations between oxidized LDL to LDL ratio, HDL and vascular calcification in the feet of hemodialysis patients.

Authors:  Won Suk An; Seong-Eun Kim; Ki-Hyun Kim; Hae-Rahn Bae; Seo-Hee Rha
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153

10.  Serum lipid profile constituents as markers of cardiovascular morbidity in patients on chronic hemodialysis.

Authors:  Dimitrios Kirmizis; Evangelia Koutoupa; Apostolos Tsiandoulas; Aphroditi Valtopoulou; Georgios Niavis; Phani Markou; Konstantinos Barboutis
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.